3 Results for "

DM-3189 dihydrochloride (Standard)

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "DM-3189 dihydrochloride (Standard)" in MCE Product Catalog:

Cat. No.: HY-12071BR
CAS No.: 1435934-00-1
Synonyms: DM-3189 dihydrochloride (Standard)
Research Areas:  

Cancer

LDN193189 (DM-3189) dihydrochloride (Standard) is the analytical standard of LDN193189 dihydrochloride (HY-12071B). This product is intended for research and analytical applications. LDN193189 (DM-3189) dihydrochloride is a potent selective BMP type I receptor (BMP I) inhibitor. LDN193189 efficiently inhibits transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 values of 5 nM and 30 nM, respectively. LDN193189 can be used for the research of bone morphogenetic protein signalling, such as fibrodysplasia ossificans progressiva .
loading...
    loading...
Cat. No.: HY-12071AR
CAS No.: 2310134-98-4
Synonyms: DM-3189 Tetrahydrochloride (Standard)
Research Areas:  

Cancer

LDN193189 (DM-3189) Tetrahydrochloride (Standard) is the analytical standard of LDN193189 Tetrahydrochloride (HY-12071A). This product is intended for research and analytical applications. LDN193189 (DM-3189) Tetrahydrochloride is a potent selective BMP type I receptor (BMP I) inhibitor. LDN193189 efficiently inhibits transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 values of 5 nM and 30 nM, respectively. LDN193189 can be used for the research of bone morphogenetic protein signalling, such as fibrodysplasia ossificans progressiva .
loading...
    loading...
Cat. No.: HY-12071R
CAS No.: 1062368-24-4
Synonyms: DM-3189 (Standard)
Research Areas:  

Cancer

LDN193189 (Standard) is the analytical standard of LDN193189 (HY-12071). This product is intended for research and analytical applications. LDN193189 (DM-3189) is a potent selective BMP type I receptor (BMP I) inhibitor. LDN193189 efficiently inhibits transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 values of 5 nM and 30 nM, respectively. LDN193189 can be used for the research of bone morphogenetic protein signalling, such as fibrodysplasia ossificans progressiva .
loading...
    loading...